Neurology and Neurosurgery

17-25 of 25

• 

  RestartResume

  Novel Mechanisms of Action: FcRn Inhibitors

  RestartResume

  Novel Mechanisms of Action: FcRn Inhibitors

  MinuteCE®

  Novel Mechanisms of Action: FcRn Inhibitors

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  RestartResume

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  MinuteCE®

  Implementing CIDP Clinical Guidelines: Optimizing Therapy

  Nicholas J. Silvestri, MD; Jeffrey Allen, MD

  1.00 program credit

  • 

    

    Nicholas J. Silvestri, MD

  • 

    

    Jeffrey Allen, MD

  1.00 program credit

• 

  RestartResume

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  RestartResume

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  MinuteCE®

  CIDP Monitoring Challenges: Suboptimal Responses in CIDP Treatment

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  MinuteCE®

  Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 credit 10 episodes

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 credit 10 episodes

• 

  RestartResume

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  RestartResume

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  MinuteCE®

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  RestartResume

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  MinuteCE®

   Pinpointing CIDP: Diagnosis Challenges and Misdiagnosis/Delayed Diagnosis of CIDP

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  RestartResume

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  MinuteCE®

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Decoding CIDP: Exploring Common and Atypical Variants

  RestartResume

  Decoding CIDP: Exploring Common and Atypical Variants

  MinuteCE®

  Decoding CIDP: Exploring Common and Atypical Variants

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  RestartResume

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  MinuteCE®

  Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit